Moneycontrol
HomeNewsBusinessWinds of change as banks push for video KYC, digital channels to acquire customers 

Winds of change as banks push for video KYC, digital channels to acquire customers 

Buoyed by RBI’s video KYC guidelines, banks are looking for a faster, cheaper way of getting new customers as social distancing becomes the new normal.

June 03, 2020 / 11:15 IST
Story continues below Advertisement

The coronavirus outbreak and the recent regulatory changes in the digitised know your customer (KYC) norms can dramatically alter banking in India, changing the way banks acquire new customers.

The viral outbreak had fast-tracked the digitisation drive and the Reserve Bank of India’s video KYC guidelines not only made it quicker to open new accounts but it worked out cheaper as well, bankers said. 

Story continues below Advertisement

“Digital customer acquisition will help us concentrate physical meetings only for select account holders and this way our cost of operations will reduce and geographical reach will also go up,” said Surinder Chawla, head of retail liabilities and wealth management at RBL Bank.

If the cost of acquiring a customer through the physical channel was around Rs 2,000, the same for digital would be around Rs 200, he said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show